Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interference with clinical laboratory analyses

M H Kroll1, R J Elin

  • 1Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892.

Clinical Chemistry
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation.

Platelets·2010
Same author

Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries.

Platelets·2010
Same author

Exogenous interferences with Jaffe creatinine assays: addition of sodium dodecyl sulfate to reagent eliminates bilirubin and total protein interference with Jaffe methods.

Journal of clinical laboratory analysis·2010
Same author

How to use linear regression and correlation in quantitative method comparison studies.

International journal of clinical practice·2008
Same author

Protease-activated receptor-induced Akt activation--regulation and possible function.

Journal of thrombosis and haemostasis : JTH·2007

Substances like hemoglobin, bilirubin, lipids, and drugs can interfere with clinical lab tests. Identifying and resolving these interferences is crucial for accurate laboratory medicine results.

Area of Science:

  • Laboratory Medicine
  • Clinical Chemistry
  • Analytical Toxicology

Background:

  • Substance interference is a frequent challenge in clinical laboratory assays.
  • Interference is defined as a substance altering the true result of an analyte.
  • Endogenous (hemoglobin, bilirubin, lipids, paraproteins) and exogenous (drugs) substances are primary sources.

Purpose of the Study:

  • To define and categorize common sources of interference in clinical laboratory assays.
  • To propose a systematic approach for identifying and resolving interference issues.
  • To provide recommendations for assay manufacturers regarding interference mitigation.

Main Methods:

  • Literature review of endogenous and exogenous interference sources.
  • Definition and categorization of interference types.

Related Experiment Videos

  • Development of a framework for interference problem-solving.

    • Main Results:

    • Identified four major endogenous interfering substances: hemoglobin, bilirubin, lipids, and paraproteins.
    • Highlighted prescribed drugs as significant exogenous sources of interference.
    • Distinguished between analyte-dependent and analyte-independent interference.

    Conclusions:

    • Accurate clinical analyte measurement requires addressing substance interference.
    • A structured approach aids in identifying and resolving interference problems in the lab.
    • Collaboration with manufacturers is recommended to improve assay robustness against interference.